Effects of chronic treatment with citalopram on cannabinoid and opioid receptor-mediated G-protein coupling in discrete rat brain regions

被引:20
|
作者
Hesketh, Shirley A. [2 ]
Brennan, Adrian K. [1 ]
Jessop, David S. [2 ]
Finn, David P. [1 ]
机构
[1] Natl Univ Ireland Univ Coll Cork, Ctr Pain Res, Dept Pharmacol & Therapeut, Natl Ctr Biomed Engn Sci Neurosci Cluster, Galway, Ireland
[2] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol BS1 3NY, Avon, England
基金
爱尔兰科学基金会;
关键词
antidepressant; rat; cannabinoids; opioid receptor; paraventricular nucleus; hippocampus; S-35]GTP gamma S autoradiography;
D O I
10.1007/s00213-007-1033-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale There is growing interest in investigating the mechanisms of action of selective serotonin reuptake inhibitors (SSRIs), beyond their association with the serotonergic system, due to their wide therapeutic potential for disorders including depression, pain and addiction. Objective The aim of this study was to investigate whether chronic treatment with the SSRI, citalopram, alters the functional coupling of G(i/o)-associated cannabinoid type 1 (CB1) and mu-opioid receptors in selected areas of rat brain implicated in psychiatric disorders and pain. Methods Using an autoradiographic approach, the effects of the cannabinoid receptor agonist, HU210 (in the presence or absence of the CB1 receptor antagonist AM251), or the mu-opioid receptor agonist, [D-Ala(2),N-Me-Phe4,Gly(5)-ol]-enkephalin (DAMGO; in the presence or absence of the mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2), on [S-35]GTP gamma S binding in discrete brain regions of citalopram-treated (10 mg kg(-1) day(-1) for 14 days by subcutaneous minipump) and control rats were investigated. Results The HU210-induced increase in [S-35]GTP gamma S binding observed in the hypothalamic paraventricular nucleus of control rats was abolished after chronic treatment with citalopram. Reduced response to HU210 in rats receiving chronic treatment with citalopram was also observed in the hippocampus and medial geniculate nucleus. Citalopram had no significant effect on DAMGO-induced [S-35]GTP gamma S binding in the brain regions investigated, with the exception of the medial geniculate nucleus where a modest impairment was observed. Conclusions These data provide evidence for reduced cannabinoid receptor-mediated G-protein coupling in the hypothalamus, hippocampus and medial geniculate nucleus of rats chronically treated with citalopram, effects which may, in part, underlie the mechanism of action of SSRIs.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 50 条
  • [1] Effects of chronic treatment with citalopram on cannabinoid and opioid receptor-mediated G-protein coupling in discrete rat brain regions
    Shirley A. Hesketh
    Adrian K. Brennan
    David S. Jessop
    David P. Finn
    Psychopharmacology, 2008, 198 : 29 - 36
  • [2] Effect of strain and sex on μ opioid receptor-mediated G-protein activation in rat brain
    Selley, DE
    Herbert, JT
    Morgan, D
    Cook, CD
    Picker, MJ
    Sim-Selley, LJ
    BRAIN RESEARCH BULLETIN, 2003, 60 (03) : 201 - 208
  • [3] Regional differences in cannabinoid receptor G-protein coupling in rat brain
    Breivogel, CS
    Sim, LJ
    Childers, SR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 282 (03): : 1632 - 1642
  • [4] Chronic ethanol consumption reduces δ- and μ-opioid receptor-stimulated G-protein coupling in rat brain
    Saland, LC
    Abeyta, A
    Frausto, S
    Raymond-Stintz, M
    Hastings, CM
    Carta, M
    Valenzuela, CF
    Savage, DD
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (01) : 98 - 104
  • [5] Chronic neuropathic pain in mice reduces μ-opioid receptor-mediated G-protein activity in the thalamus
    Hoot, Michelle R.
    Sim-Selley, Laura J.
    Selley, Dana E.
    Scoggins, Krista L.
    Dewey, William L.
    BRAIN RESEARCH, 2011, 1406 : 1 - 7
  • [6] Mu-Opioid (MOP) receptor mediated G-protein signaling is impaired in specific brain regions in a rat model of schizophrenia
    Szucs, Edina
    Buki, Alexandra
    Kekesi, Gabriella
    Horvath, Gyongyi
    Benyhe, Sandor
    NEUROSCIENCE LETTERS, 2016, 619 : 29 - 33
  • [7] Age-dependent increase in opioid receptor-mediated G-protein activation in postmortem human brain membranes
    Odagaki, Yuji
    Kinoshita, Masakazu
    Ota, Toshio
    Javier Meana, J.
    Callado, Luis F.
    Garcia-Sevilla, Jesus A.
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S134 - S134
  • [8] Agonists determine the pattern of G-protein activation in μ-opioid receptor-mediated supraspinal analgesia
    Sánchez-Blázquez, P
    Gómez-Serranillos, P
    Garzón, J
    BRAIN RESEARCH BULLETIN, 2001, 54 (02) : 229 - 235
  • [9] Effect of ethanol self-administration on μ- and δ-opioid receptor-mediated G-protein activity
    Sim-Selley, LJ
    Sharpe, AL
    Vogt, LJ
    Brunk, LK
    Selley, DE
    Samson, HH
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2002, 26 (05) : 688 - 694
  • [10] HALOTHANE DISRUPTION OF ALPHA-2-ADRENERGIC RECEPTOR-MEDIATED INHIBITION OF ADENYLATE-CYCLASE AND RECEPTOR G-PROTEIN COUPLING IN RAT-BRAIN
    BAUMGARTNER, MK
    DENNISON, RL
    NARAYANAN, TK
    ARONSTAM, RS
    BIOCHEMICAL PHARMACOLOGY, 1990, 39 (01) : 223 - 225